The Clorox Company (NYSE:CLX) Shares Bought by Rafferty Asset Management LLC

Rafferty Asset Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 4.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,626 shares of the company’s stock after purchasing an additional 395 shares during the quarter. Rafferty Asset Management LLC’s holdings in Clorox were worth $1,373,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Choreo LLC grew its holdings in Clorox by 12.8% in the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after buying an additional 652 shares during the period. abrdn plc boosted its holdings in shares of Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after purchasing an additional 33,135 shares during the last quarter. Savoir Faire Capital Management L.P. raised its position in shares of Clorox by 61.8% in the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock worth $9,296,000 after buying an additional 24,897 shares during the period. International Assets Investment Management LLC raised its position in shares of Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. Finally, Victory Capital Management Inc. boosted its holdings in Clorox by 3.9% in the fourth quarter. Victory Capital Management Inc. now owns 172,526 shares of the company’s stock valued at $24,600,000 after acquiring an additional 6,510 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX opened at $131.71 on Tuesday. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company’s 50-day moving average price is $139.42 and its 200 day moving average price is $144.50. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.14. The firm has a market cap of $16.36 billion, a price-to-earnings ratio of 68.24, a price-to-earnings-growth ratio of 2.05 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.51 EPS. As a group, sell-side analysts expect that The Clorox Company will post 5.83 earnings per share for the current year.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research analyst reports. Morgan Stanley reissued an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. UBS Group lowered their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Finally, Argus raised shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Four research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $146.43.

View Our Latest Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.